Data as of May 21
| -0.37 / -0.56%|
The 17 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 75.00, with a high estimate of 92.00 and a low estimate of 64.00. The median estimate represents a +13.64% increase from the last price of 66.00.
The current consensus among 26 polled investment analysts is to Hold stock in Edwards Lifesciences Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.